Figure 2. Opportunities for combination therapy.
A simplified schematic of KRAS signaling along with inhibitors targeting various intermediates reported to modulate KRAS(G12C) inhibition. Solid lines indicate a direct effect whereas dotted lines indicate indirect effects. Colors denote signaling intermediates along the same pathway.